Terms: = Head and neck cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
107 results:
1. DKK3 expression is correlated with poorer prognosis in head and neck squamous cell carcinoma: A bioinformatics study based on the TCGA database.
Katase N; Nishimatsu SI; Yamauchi A; Okano S; Fujita S
J Oral Biosci; 2023 Dec; 65(4):334-346. PubMed ID: 37716425
[TBL] [Abstract] [Full Text] [Related]
2. The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.
Iesato A; Li S; Sadow PM; Abbasian M; Nazarian A; Lawler J; Nucera C
Thyroid; 2023 Jul; 33(7):835-848. PubMed ID: 37171127
[No Abstract] [Full Text] [Related]
3. The participation of tumor residing pericytes in oral squamous cell carcinoma.
do Valle IB; Oliveira SR; da Silva JM; Peterle GT; Có ACG; Sousa-Neto SS; Mendonça EF; de Arruda JAA; Gomes NA; da Silva G; Leopoldino AM; Macari S; Birbrair A; von Zeidler SV; Diniz IMA; Silva TA
Sci Rep; 2023 Apr; 13(1):5460. PubMed ID: 37015965
[TBL] [Abstract] [Full Text] [Related]
4. Identification of gene profiles related to the development of oral cancer using a deep learning technique.
Tapak L; Ghasemi MK; Afshar S; Mahjub H; Soltanian A; Khotanlou H
BMC Med Genomics; 2023 Feb; 16(1):35. PubMed ID: 36849997
[TBL] [Abstract] [Full Text] [Related]
5. cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhu L; Zhang X; Zhang S; Zhang Q; Cao L; Zhang Y; Wang D; Liang X; Wu W; Wu S; Jiang R; Liu Y; Zhao X; Zhou G; Xu K; Meng Z
Clin Exp Med; 2023 Oct; 23(6):2209-2220. PubMed ID: 36715834
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Value of WNT1, NOTCH1, pdgfrβ, and CXCR4 in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Anticancer Res; 2023 Feb; 43(2):591-602. PubMed ID: 36697060
[TBL] [Abstract] [Full Text] [Related]
7. Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).
Kamimura A; Nakamura Y; Takenouchi T; Matsushita S; Omodaka T; Yamamura K; Uchi H; Yoshikawa S; Yanagisawa H; Ito T; Kiyohara Y; Nakamura Y; Aoki M; Ishizuki S; Oashi K; Miyagawa T; Maeda T; Ogata D; Hatta N; Ohe S; Isei T; Takahashi A; Umeda Y; Yamaguchi B; Ishikawa M; Horimoto K; Fujsawa Y; Uehara J; Shibayama Y; Kiniwa Y; Kawahara Y; Matsuya T; Uhara H; Kato J; Nakamura Y; Murakami T; Namikawa K; Yoshino K; Funakoshi T; Takatsuka S; Matsui Y; Sasaki J; Koga H; Yokota K; Komori T; Fukushima S; Yamazaki N
J Dermatol; 2022 Sep; 49(9):837-844. PubMed ID: 35510662
[TBL] [Abstract] [Full Text] [Related]
8. A Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma.
Zhang Y; Luo F; Ma YX; Liu QW; Yang YP; Fang WF; Huang Y; Zhou T; Li J; Pan HM; Yang L; Qin SK; Zhao HY; Zhang L
Oncologist; 2022 Jun; 27(6):e453-e462. PubMed ID: 35445718
[TBL] [Abstract] [Full Text] [Related]
9. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
10. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
[TBL] [Abstract] [Full Text] [Related]
11. Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.
Moy RH; Greally M; Chou JF; Li J; Desai AM; Chalasani SB; Won E; Kelsen DP; Ilson DH; Janjigian YY; Capanu M; Ku GY
Cancer Chemother Pharmacol; 2022 Feb; 89(2):255-265. PubMed ID: 35066693
[TBL] [Abstract] [Full Text] [Related]
12. Determination of cytokine profile and associated genes of the signaling pathway in HNSCC.
Kalayci Yigin A; Azzawri A; Ozturk K; Cora T; Seven M
J Recept Signal Transduct Res; 2022 Oct; 42(5):462-468. PubMed ID: 34886759
[TBL] [Abstract] [Full Text] [Related]
13. Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid cancer.
Iesato A; Nucera C
Adv Exp Med Biol; 2021; 1329():253-269. PubMed ID: 34664244
[TBL] [Abstract] [Full Text] [Related]
14. Lenvatinib Targets pdgfr-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
Iesato A; Li S; Roti G; Hacker MR; Fischer AH; Nucera C
J Clin Endocrinol Metab; 2021 Nov; 106(12):3569-3590. PubMed ID: 34302727
[TBL] [Abstract] [Full Text] [Related]
15. The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis.
Liang J; Jin Z; Kuang J; Feng H; Zhao Q; Yang Z; Zhan L; Shen B; Yan J; Cai W; Cheng X; Qiu W
Br J Cancer; 2021 Aug; 125(3):390-401. PubMed ID: 34088989
[TBL] [Abstract] [Full Text] [Related]
16. A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.
Duan X; Shang X; Yue J; Ma Z; Chen C; Tang P; Jiang H; Yu Z
BMC Cancer; 2021 Apr; 21(1):431. PubMed ID: 33879102
[TBL] [Abstract] [Full Text] [Related]
17. Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Li D; Chi Y; Chen X; Ge M; Zhang Y; Guo Z; Wang J; Chen J; Zhang J; Cheng Y; Li Z; Liu H; Qin J; Zhu J; Cheng R; Xu Z; Zheng X; Tang P; Gao M
Clin Cancer Res; 2021 Jul; 27(13):3567-3575. PubMed ID: 33832949
[TBL] [Abstract] [Full Text] [Related]
18. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I; Lam AK
Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
[TBL] [Abstract] [Full Text] [Related]
19. Mining of gene modules and identification of key genes in head and neck squamous cell carcinoma based on gene co-expression network analysis.
Zhao Q; Zhang Y; Zhang X; Sun Y; Lin Z
Medicine (Baltimore); 2020 Dec; 99(49):e22655. PubMed ID: 33285674
[TBL] [Abstract] [Full Text] [Related]
20. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
[TBL] [Abstract] [Full Text] [Related]
[Next]
